Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways

The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of comparative neurology (1911) 1995-05, Vol.355 (4), p.615-628
Hauptverfasser: Miller, Brad, Sheppard, Allan M., Bicknese, Alma R., Pearlman, Alan L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 628
container_issue 4
container_start_page 615
container_title Journal of comparative neurology (1911)
container_volume 355
creator Miller, Brad
Sheppard, Allan M.
Bicknese, Alma R.
Pearlman, Alan L.
description The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.
doi_str_mv 10.1002/cne.903550410
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77438457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77438457</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</originalsourceid><addsrcrecordid>eNp9kc1uEzEUhS0EKmlhyRLJK3ZT7HrGP-wgLQEpKpsiJDaWx3PdGCZ2sD00eRjetQ6JIlZsbFnnnE_X9yD0ipJLSsjVWxvgUhHWdaSl5AmaUaJ4oySnT9Gs6rRRiovn6DznH4QQpZg8Q2eCM14zM_RnvophSNEXH3CeRmcK4E2KBeL9uLMmZFyFsgI8wG8Y48aHe2whQZ_MiG1MBbbv8N1e97kk30_Fx4CjwwGmFCvgr1BTk88ryNjFtN4zjHOVEgo2YcBwemxjqNyNKasHs8sv0DNnxgwvj_cF-vrx5m7-qVl-WXyev182tm0JaZxprWHyygEF13VSSck7xgU4Vk_Rqn6QwwCDkKzlzMneCsUddYQL6bhU7AK9OXDrz39NkIte-2xhHE2AOGVdGUy2najG5mC0KeacwOlN8muTdpoSva9D1zr0qY7qf30ET_0ahpP7uP-qi4P-4EfY_R-m57c3_5KPk9TtwvaUNOmn5oKJTn-7XejFtWIf5LLT39kj6jSpkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77438457</pqid></control><display><type>article</type><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</creator><creatorcontrib>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</creatorcontrib><description>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</description><identifier>ISSN: 0021-9967</identifier><identifier>EISSN: 1096-9861</identifier><identifier>DOI: 10.1002/cne.903550410</identifier><identifier>PMID: 7636035</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Afferent Pathways - cytology ; Afferent Pathways - embryology ; Afferent Pathways - metabolism ; Animals ; Antibodies, Monoclonal ; Axons - metabolism ; Cerebral Cortex - cytology ; Cerebral Cortex - embryology ; Cerebral Cortex - metabolism ; Chondroitin Lyases ; Chondroitin Sulfate Proteoglycans - metabolism ; Chondroitin Sulfates - metabolism ; development ; Efferent Pathways - cytology ; Efferent Pathways - embryology ; Efferent Pathways - metabolism ; extracellular matrix ; Female ; glycosaminoglycan ; Glycosaminoglycans - metabolism ; Immunohistochemistry ; Lectins, C-Type ; Nerve Tissue Proteins - metabolism ; Pregnancy ; Rats ; Thalamus - cytology ; Thalamus - embryology ; Thalamus - metabolism ; Vibrissae - innervation</subject><ispartof>Journal of comparative neurology (1911), 1995-05, Vol.355 (4), p.615-628</ispartof><rights>Copyright © 1995 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</citedby><cites>FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcne.903550410$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcne.903550410$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7636035$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miller, Brad</creatorcontrib><creatorcontrib>Sheppard, Allan M.</creatorcontrib><creatorcontrib>Bicknese, Alma R.</creatorcontrib><creatorcontrib>Pearlman, Alan L.</creatorcontrib><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><title>Journal of comparative neurology (1911)</title><addtitle>J. Comp. Neurol</addtitle><description>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</description><subject>Afferent Pathways - cytology</subject><subject>Afferent Pathways - embryology</subject><subject>Afferent Pathways - metabolism</subject><subject>Animals</subject><subject>Antibodies, Monoclonal</subject><subject>Axons - metabolism</subject><subject>Cerebral Cortex - cytology</subject><subject>Cerebral Cortex - embryology</subject><subject>Cerebral Cortex - metabolism</subject><subject>Chondroitin Lyases</subject><subject>Chondroitin Sulfate Proteoglycans - metabolism</subject><subject>Chondroitin Sulfates - metabolism</subject><subject>development</subject><subject>Efferent Pathways - cytology</subject><subject>Efferent Pathways - embryology</subject><subject>Efferent Pathways - metabolism</subject><subject>extracellular matrix</subject><subject>Female</subject><subject>glycosaminoglycan</subject><subject>Glycosaminoglycans - metabolism</subject><subject>Immunohistochemistry</subject><subject>Lectins, C-Type</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Thalamus - cytology</subject><subject>Thalamus - embryology</subject><subject>Thalamus - metabolism</subject><subject>Vibrissae - innervation</subject><issn>0021-9967</issn><issn>1096-9861</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1uEzEUhS0EKmlhyRLJK3ZT7HrGP-wgLQEpKpsiJDaWx3PdGCZ2sD00eRjetQ6JIlZsbFnnnE_X9yD0ipJLSsjVWxvgUhHWdaSl5AmaUaJ4oySnT9Gs6rRRiovn6DznH4QQpZg8Q2eCM14zM_RnvophSNEXH3CeRmcK4E2KBeL9uLMmZFyFsgI8wG8Y48aHe2whQZ_MiG1MBbbv8N1e97kk30_Fx4CjwwGmFCvgr1BTk88ryNjFtN4zjHOVEgo2YcBwemxjqNyNKasHs8sv0DNnxgwvj_cF-vrx5m7-qVl-WXyev182tm0JaZxprWHyygEF13VSSck7xgU4Vk_Rqn6QwwCDkKzlzMneCsUddYQL6bhU7AK9OXDrz39NkIte-2xhHE2AOGVdGUy2najG5mC0KeacwOlN8muTdpoSva9D1zr0qY7qf30ET_0ahpP7uP-qi4P-4EfY_R-m57c3_5KPk9TtwvaUNOmn5oKJTn-7XejFtWIf5LLT39kj6jSpkw</recordid><startdate>19950515</startdate><enddate>19950515</enddate><creator>Miller, Brad</creator><creator>Sheppard, Allan M.</creator><creator>Bicknese, Alma R.</creator><creator>Pearlman, Alan L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950515</creationdate><title>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</title><author>Miller, Brad ; Sheppard, Allan M. ; Bicknese, Alma R. ; Pearlman, Alan L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4400-fa4ca382fe1ef55898865367ef3367749bd8dded783463f8bc796f1f0678f6893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Afferent Pathways - cytology</topic><topic>Afferent Pathways - embryology</topic><topic>Afferent Pathways - metabolism</topic><topic>Animals</topic><topic>Antibodies, Monoclonal</topic><topic>Axons - metabolism</topic><topic>Cerebral Cortex - cytology</topic><topic>Cerebral Cortex - embryology</topic><topic>Cerebral Cortex - metabolism</topic><topic>Chondroitin Lyases</topic><topic>Chondroitin Sulfate Proteoglycans - metabolism</topic><topic>Chondroitin Sulfates - metabolism</topic><topic>development</topic><topic>Efferent Pathways - cytology</topic><topic>Efferent Pathways - embryology</topic><topic>Efferent Pathways - metabolism</topic><topic>extracellular matrix</topic><topic>Female</topic><topic>glycosaminoglycan</topic><topic>Glycosaminoglycans - metabolism</topic><topic>Immunohistochemistry</topic><topic>Lectins, C-Type</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Thalamus - cytology</topic><topic>Thalamus - embryology</topic><topic>Thalamus - metabolism</topic><topic>Vibrissae - innervation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miller, Brad</creatorcontrib><creatorcontrib>Sheppard, Allan M.</creatorcontrib><creatorcontrib>Bicknese, Alma R.</creatorcontrib><creatorcontrib>Pearlman, Alan L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of comparative neurology (1911)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miller, Brad</au><au>Sheppard, Allan M.</au><au>Bicknese, Alma R.</au><au>Pearlman, Alan L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways</atitle><jtitle>Journal of comparative neurology (1911)</jtitle><addtitle>J. Comp. Neurol</addtitle><date>1995-05-15</date><risdate>1995</risdate><volume>355</volume><issue>4</issue><spage>615</spage><epage>628</epage><pages>615-628</pages><issn>0021-9967</issn><eissn>1096-9861</eissn><abstract>The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7636035</pmid><doi>10.1002/cne.903550410</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9967
ispartof Journal of comparative neurology (1911), 1995-05, Vol.355 (4), p.615-628
issn 0021-9967
1096-9861
language eng
recordid cdi_proquest_miscellaneous_77438457
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Afferent Pathways - cytology
Afferent Pathways - embryology
Afferent Pathways - metabolism
Animals
Antibodies, Monoclonal
Axons - metabolism
Cerebral Cortex - cytology
Cerebral Cortex - embryology
Cerebral Cortex - metabolism
Chondroitin Lyases
Chondroitin Sulfate Proteoglycans - metabolism
Chondroitin Sulfates - metabolism
development
Efferent Pathways - cytology
Efferent Pathways - embryology
Efferent Pathways - metabolism
extracellular matrix
Female
glycosaminoglycan
Glycosaminoglycans - metabolism
Immunohistochemistry
Lectins, C-Type
Nerve Tissue Proteins - metabolism
Pregnancy
Rats
Thalamus - cytology
Thalamus - embryology
Thalamus - metabolism
Vibrissae - innervation
title Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A36%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chondroitin%20sulfate%20proteoglycans%20in%20the%20developing%20cerebral%20cortex:%20The%20distribution%20of%20neurocan%20distinguishes%20forming%20afferent%20and%20efferent%20axonal%20pathways&rft.jtitle=Journal%20of%20comparative%20neurology%20(1911)&rft.au=Miller,%20Brad&rft.date=1995-05-15&rft.volume=355&rft.issue=4&rft.spage=615&rft.epage=628&rft.pages=615-628&rft.issn=0021-9967&rft.eissn=1096-9861&rft_id=info:doi/10.1002/cne.903550410&rft_dat=%3Cproquest_cross%3E77438457%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77438457&rft_id=info:pmid/7636035&rfr_iscdi=true